How to improve drug dosing for patients with renal impairment in primary care - A cluster-randomized controlled trial

BMC Family Practice

Volumn 13, Issue , 2012, Pages

  Erler, Antje ^a   Beyer, Martin ^a   Petersen, Juliana J ^a   Saal, Kristina ^a   Rath, Thomas ^b   Rochon, Justine ^c   Haefeli, Walter E ^d   Gerlach, Ferdinand M ^a  

^a GOETHE UNIVERSITY   (Germany)

^b ST FRANZISKUS HOSPITAL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PRESCRIPTION DRUG;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECISION SUPPORT SYSTEM; DOSE CALCULATION; EDUCATION; FEMALE; GENERAL PRACTICE; GERMANY; HUMAN; HYPERTENSION; MALE; METHODOLOGY; MIDDLE AGED; OUTCOME ASSESSMENT; PRIMARY HEALTH CARE; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; DECISION MAKING, COMPUTER-ASSISTED; DRUG DOSAGE CALCULATIONS; DRUG THERAPY, COMPUTER-ASSISTED; FEMALE; GENERAL PRACTICE; GERMANY; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PRESCRIPTION DRUGS; PRIMARY HEALTH CARE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84865754033     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-13-91     Document Type: Article

References (51)

1. The kidney disease initiative and the division of diabetes translation at the centers for disease control and prevention. Albright A, Burrows NR, Jordan R, Williams DE, Am J Kidney Dis 2009 53 121 S125 10.1053/j.ajkd.2008.06.037 19231756
2. Prevalence of chronic kidney disease in the United States. Coresh J, Selvin E, Stevens LA, Manzi J, Kusek JW, Eggers P, et al. JAMA 2007 298 2038 2047 10.1001/jama.298.17.2038 17986697 (Pubitemid 350074801)
3. Chronic kidney disease: a public health problem that needs a public health action plan. Schoolwerth AC, Engelgau MM, Hostetter TH, Rufo KH, Chianchiano D, McClellan WM, et al. Prev Chronic Dis 2006 3 57 16539798
4. Who should be targeted for CKD screening? impact of diabetes, hypertension, and cardiovascular disease. Collins AJ, Vassalotti JA, Wang C, Li S, Gilbertson DT, Liu J, et al. Am J Kidney Dis 2009 53 71 S77 10.1053/j.ajkd.2008.07.057 19231764
5. Diabetes, cardiovascular risk and nephropathy. Hahr AJ, Molitch ME, Cardiol Clin 2010 28 467 475 10.1016/j.ccl.2010.04.006 20621251
6. Chronic kidney disease and older people-implications of the publication of the part 2 of the national service framework for renal services. ORiordan S, Age Ageing 2005 34 546 548 10.1093/ageing/afi181 16267175 (Pubitemid 41699993)
7. Chronic kidney disease and end-stage renal disease in the elderly population: current prevalence, future projections, and clinical significance. Stevens LA, Viswanathan G, Weiner DE, Adv Chronic Kidney Dis 2010 17 293 301 10.1053/j.ackd.2010.03.010 20610356
8. Paroux L, utret-Leca E: assessing general practitioners prescribing behaviour in elderly patients with concealed renal failure. Jonville-Bera AP, Br J Clin Pharmacol 2008 65 961 963 10.1111/j.1365-2125.2008.03127.x 18341682 (Pubitemid 351677435)
9. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY, N Engl J Med 2004 351 1296 1305 10.1056/NEJMoa041031 15385656 (Pubitemid 39268908)
10. Potential application of the National Kidney Foundations chronic kidney disease guidelines in a managed care setting. Thorp ML, Eastman L, Am J Manag Care 2004 10 417 422 15298363 (Pubitemid 38970238)
11. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis. Black C, Sharma P, Scotland G, McCullough K, McGurn D, Robertson L, et al. Health Technol Assess 2010 14 1 184 21208547
12. CKD awareness and blood pressure control in the primary care hypertensive population. Ravera M, Noberasco G, Weiss U, Re M, Gallina AM, Filippi A, et al. Am J Kidney Dis 2011 57 71 77 10.1053/j.ajkd.2010.08.022 21087817
13. High prevalence of stage 3 chronic kidney disease in older adults despite normal serum creatinine. Duru OK, Vargas RB, Kermah D, Nissenson AR, Norris KC, J Gen Intern Med 2009 24 86 92 10.1007/s11606-008-0850-3 18987917
14. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Swedko PJ, Clark HD, Paramsothy K, Akbari A, Arch Intern Med 2003 163 356 360 10.1001/archinte.163.3.356 12578517 (Pubitemid 36183865)
15. The old and new methods of assessing kidney function. Steffl JL, Bennett W, Olyaei AJ, J Clin Pharmacol 2012 52 63S 71S 10.1177/0091270011420260 22232755
16. Drug dosing in patients with impaired renal function. Brater DC, Clin Pharmacol Ther 2009 86 483 489 10.1038/clpt.2009.135 19626002
17. Adverse drug effects in relation to renal function. Jick H, Am J Med 1977 62 514 517 10.1016/0002-9343(77)90406-5 851122
18. Dose individualisation in patients with renal insufficiency: does drug labelling support optimal management? Martin-Facklam M, Rengelshausen J, Tayrouz Y, Ketabi-Kiyanvash N, Lindenmaier H, Schneider V, et al. Eur J Clin Pharmacol 2005 60 807 811 10.1007/s00228-004-0852-y 15599503 (Pubitemid 40394575)
19. Evaluation of dosage adjustment in patients with renal impairment. Pillans PI, Landsberg PG, Fleming AM, Fanning M, Sturtevant JM, Intern Med J 2003 33 10 13 10.1046/j.1445-5994.2003.00330.x 12534872 (Pubitemid 36241568)
20. Pro-active provision of drug information as a technique to address overdosing in intensive-care patients with renal insufficiency. Bertsche T, Fleischer M, Pfaff J, Encke J, Czock D, Haefeli WE, Eur J Clin Pharmacol 2009 65 823 829 10.1007/s00228-009-0643-6 19319510
21. Drug dosage in patients with renal failure optimized by immediate concurrent feedback. Falconnier AD, Haefeli WE, Schoenenberger RA, Surber C, Martin-Facklam M, J Gen Intern Med 2001 16 369 375 10.1046/j.1525-1497.2001. 016006369.x 11422633 (Pubitemid 34205654)
22. Computerized decision support for medication dosing in renal insufficiency: a randomized, controlled trial. Terrell KM, Perkins AJ, Hui SL, Callahan CM, Dexter PR, Miller DK, Ann Emerg Med 2010 56 623 629 10.1016/j.annemergmed.2010.03.025 20452703
23. Guided medication dosing for inpatients with renal insufficiency. Chertow GM, Lee J, Kuperman GJ, Burdick E, Horsky J, Seger DL, et al. JAMA 2001 286 2839 2844 10.1001/jama.286.22.2839 11735759 (Pubitemid 33126926)
24. The primary care-specialty income gap: why it matters. Bodenheimer T, Berenson RA, Rudolf P, Ann Intern Med 2007 146 301 306 17310054 (Pubitemid 351650616)
25. American Academy of Family Physicians, Practice profile of family physicians by family medicine residency completion 2009 http://www.aafporg/ online/en/home/aboutus/specialty/facts/4html
26. A survey of primary care physicians in eleven countries, 2009: perspectives on care, costs, and experiences. Schoen C, Osborn R, Doty MM, Squires D, Peugh J, Applebaum S, Health Aff (Millwood) 2009 28 1171 w1183 10.1377/hlthaff.28.6.w1171
27. Case management for depression by health care assistents in small primary care practices: a cluster randomized trial. Gensichen J, von Korff M, Peitz M, Muth C, Beyer M, Gthlin C, Torge M, Petersen JJ, Rosemann T, Knig J, Gerlach FM, Ann Inter Med 2009 151 6 369 78
28. The kidney in pre-clinical and clinical pharmacokinetics. Dettli L, Jpn J Clin Pharmacol Ther 1984 15 241 254 10.3999/jscpt.15.241
29. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ, J Clin Epidemiol 2004 57 785 794 10.1016/j.jclinepi. 2003.12.013 15485730 (Pubitemid 39370161)
30. Sample size calculations for cluster randomised trials. changing professional practice in Europe group (EU BIOMED II Concerted Action). Campbell M, Grimshaw J, Steen N, J Health Serv Res Policy 2000 5 12 16 10787581
31. Efficacy and safety of benazepril for advanced chronic renal insufficiency. Hou FF, Zhang X, Zhang GH, Xie D, Chen PY, Zhang WR, et al. N Engl J Med 2006 354 131 140 10.1056/NEJMoa053107 16407508 (Pubitemid 43076710)
32. Pharmacokinetics and pharmacodynamics of lisinopril in advanced renal failure consequence of dose adjustment. Neubeck M, Fliser D, Pritsch M, Weisser K, Fliser M, Nussberger J, et al. Eur J Clin Pharmacol 1994 46 537 543 7995322 (Pubitemid 24247930)
33. Blood pressure response to conventional and low-dose enalapril in chronic renal failure. Elung-Jensen T, Heisterberg J, Kamper AL, Sonne J, Strandgaard S, Br J Clin Pharmacol 2003 55 139 146 10.1046/j.1365-2125.2003.01764.x 12580985 (Pubitemid 36237860)
34. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Kunz R, Friedrich C, Wolbers M, Mann JF, Ann Intern Med 2008 148 30 48 17984482 (Pubitemid 351688350)
35. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving HH, Kidney Int 2003 63 1874 1880 10.1046/j.1523-1755.2003. 00940.x 12675866 (Pubitemid 36513336)
36. Metformin-associated lactic acidosis in patients with renal impairment solely due to drug accumulation? Runge S, Mayerle J, Warnke C, Robinson D, Roser M, Felix SB, et al. Diabetes Obes Metab 2008 10 91 93 18095950 (Pubitemid 350302435)
37. Drug dosing adjustments in patients with chronic kidney disease. Munar MY, Singh H, Am Fam Physician 2007 75 1487 1496 17555141 (Pubitemid 46790332)
38. Severe allopurinol toxicity. description and guidelines for prevention in patients with renal insufficiency. Hande KR, Noone RM, Stone WJ, Am J Med 1984 76 47 56 6430077 (Pubitemid 14216359)
39. Frequency of inappropriate metformin prescriptions. Horlen C, Malone R, Bryant B, Dennis B, Carey T, Pignone M, et al. JAMA 2002 287 2504 2505 10.1001/jama.287.19.2504 12020329
40. Improving prescribing safety in patients with renal insufficiency in the ambulatory setting: the Drug Renal Alert Pharmacy (DRAP) program. Bhardwaja B, Carroll NM, Raebel MA, Chester EA, Korner EJ, Rocho BE, et al. Pharmacotherapy 2011 31 346 356 10.1592/phco.31.4.346 21449624
41. Effects of computerized physician order entry and clinical decision support systems on medication safety: a systematic review. Kaushal R, Shojania KG, Bates DW, Arch Intern Med 2003 163 1409 1416 10.1001/archinte.163.12.1409 12824090 (Pubitemid 36758913)
42. Medication-related clinical decision support in computerized provider order entry systems: a review. Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, Burns G, et al. J Am Med Inform Assoc 2007 14 29 40 17068355 (Pubitemid 44909484)
43. Just what the doctor ordered. Review of the evidence of the impact of computerized physician order entry system on medication errors. Shamliyan TA, Duval S, Du J, Kane RL, Health Serv Res 2008 43 32 53 18211517 (Pubitemid 351601525)
44. The effect of computerized physician order entry with clinical decision support on the rates of adverse drug events: a systematic review. Wolfstadt JI, Gurwitz JH, Field TS, Lee M, Kalkar S, Wu W, et al. J Gen Intern Med 2008 23 451 458 10.1007/s11606-008-0504-5 18373144 (Pubitemid 351464877)
45. The use and effectiveness of electronic clinical decision support tools in the ambulatory/primary care setting: a systematic review of the literature. Bryan C, Boren SA, Inform Prim Care 2008 16 79 91 18713524
46. What may help or hinder the implementation of computerized decision support systems (CDSSs): a focus group study with physicians. Varonen H, Kortteisto T, Kaila M, Fam Pract 2008 25 162 167 10.1093/fampra/cmn020 18504253 (Pubitemid 351965934)
47. Barriers to the adoption of computerised decision support systems in general practice consultations: a qualitative study of GPs perspectives. Short D, Frischer M, Bashford J, Int J Med Inform 2004 73 357 362 10.1016/j.ijmedinf. 2004.02.001 15135754 (Pubitemid 38621995)
48. Evaluation of outpatient computerized physician medication order entry systems: a systematic review. Eslami S, Abu-Hanna A, de Keizer NF, J Am Med Inform Assoc 2007 14 400 406 10.1197/jamia.M2238 17460137 (Pubitemid 46963039)
49. Erler A: [Family practitioners evaluation of an electronic tool for dose adjustment in patients with chronic kidney disease-a qualitative study]. Leifermann M, Gerlach FM, Beyer M, Petersen JJ, Z Allg Med 2010 86 146 151
50. The future of health information technology in the patient-centered medical home. Bates DW, Bitton A, Health Aff (Millwood) 2010 29 614 621 10.1377/hlthaff.2010.0007
51. Use of metformin in the setting of mild-to-moderate renal insufficiency. Lipska KJ, Bailey CJ, Inzucchi SE, Diabetes Care 2011 34 1431 1437 10.2337/dc10-2361 21617112